58 / 78
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 30, No 1, January/February 2019
56
AFRICA
92
(7): 2506–2512.
3.
Glass TR, Ungsedhapand C, Wolbers M, Weber R, Vernazza PL,
Rickenbach M,
et al
. Prevalence of risk factors for cardiovascular
disease in HIV-infected patients over time: the Swiss HIV Cohort Study.
HIV Med
2006;
7
(6): 404–410.
4.
Islam FM, Wu J, Jansson J, Wilson DP. Relative risk of cardiovascular
disease among people living with HIV: a systematic review and meta-
analysis.
HIV Med
2012;
13
(8): 453–468.
5.
Armstrong C, Liu E, Grinspoon S, Okuma J, Spiegelman D, Guerino
C,
et al
. Dyslipidemia in an HIV-positive, antiretroviral treatment-naïve
population in Dar es Salaam, Tanzania.
J Acquired Immune Defic Syndr
2011;
57
(2): 141–145.
6.
Bavinger C, Bendavid E, Niehaus K, Olshen RA, Olkin I, Sundaram V,
et al
. Risk of cardiovascular disease from antiretroviral therapy for HIV:
a systematic review.
PLoS One
2013;
8
(3): e59551.
7.
Duprez DA, Neuhaus J, Kuller LH, Tracy R, Belloso W, De Wit S,
et al
.
Inflammation, coagulation and cardiovascular disease in HIV-infected
individuals.
PLoS One
2012;
7
(9): e44454.
8.
Prevention of recurrent heart attacks and strokes in low and middle
income populations. Evidence-based recommendations for poli-
cy makers and health professionals. Geneva, 2003 World Health
Organization. 2007.
9.
Ministry of Health. National AIDS/STI Control Program (NASCOP).
Guidelines for Antiretroviral Therapy in Kenya.
4th edn. Nairobi, Kenya:
2011. Goverment of Kenya, 2011.
10. Chobanian AV, Bakris GL, Black HR,
et al
. The seventh report of the
Joint National Committee on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure: JNC 7 report.
J Am Med Assoc
2003;
289
(19): 2560–2571.
11. Third Report of the National Cholesterol Education Program (NCEP)
Expert Panel on Detection, Evaluation, and Treatment of High
Blood Cholesterol in Adults (Adult Treatment Panel III) final report.
Circulation
2002;
106
(25): 3143.
12. Joshi MD, Ayah R, Njau EK, Wanjiru R, Kayima JK, Njeru EK,
et al
.
Prevalence of hypertension and associated cardiovascular risk factors
in an urban slum in Nairobi, Kenya: A population-based survey.
BMC
Public Health
2014;
14
: 1177.
13. Bloomfield GS, Hogan JW, Keter A, Sang E, Carter EJ, Velazquez EJ,
et
al
. Hypertension and obesity as cardiovascular risk factors among HIV
seropositive patients in western Kenya.
PLoS One
2011;
6
(7): e22288.
14. Temu TM, Kirui N, Wanjalla C, Ndungu AM, Kamano JH, Inui TS,
et
al.
Cardiovascular health knowledge and preventive practices in people
living with HIV in Kenya.
BMC Infect Dis
2015;
15
: 421.
15. Abrahams-Gessel S, Denman CA, Gaziano TA, Levitt NS, Puoane T.
Challenges facing successful scaling up of effective screening for cardio-
vascular disease by community health workers in Mexico and South
Africa: policy implications.
Health Syst Policy Res
2015;
3
(1): 26.
16. Nordestgaard BRG, Langsted A, Mora S, Kolovou G, Baum Hr,
Bruckert E,
et al.
Fasting is not routinely required for determination
of a lipid profile: clinical and laboratory implications including flag-
ging at desirable concentration cut-points: a joint consensus statement
from the European Atherosclerosis Society and European Federation of
Clinical Chemistry and Laboratory Medicine.
Eur Heart J
2016;
37
(25):
1944–1958.